UroGen Pharma Ltd Inc. (URGN) Price Performance: The Role of Share Buybacks and Stock Splits

DOYU

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. This year’s metric has recorded a Price decrease of -31.36%. However, over the past six months, we’ve seen a stronger performance of -40.81%. The price of URGN leaped by -29.64% over the last 30 days. And in the last five days, it has fallen by -29.58%.

The market performance of UroGen Pharma Ltd’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $20.70 on 06/14/24, while the lowest value for the same duration was $8.94 on 05/16/25.

52-week price history of URGN Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. UroGen Pharma Ltd’s current trading price is -64.69% away from its 52-week high, while its distance from the 52-week low is -18.23%. The stock’s price range during this period has varied between$8.94 and $20.70. The UroGen Pharma Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 9.58 million for the day, a figure considerably higher than their average daily volume of 0.54 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

UroGen Pharma Ltd (URGN) has experienced a quarterly decline of -32.13% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 337.05M and boasts a workforce of 235 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 10.55, with a change in price of -3.40. Similarly, UroGen Pharma Ltd recorded 580,073 in trading volume during the last 100 days, posting a change of -31.75%.

URGN Stock Stochastic Average

As of today, UroGen Pharma Ltd’s raw stochastic average for the last 50 days stands at 14.38%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 15.57%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 18.21% and 27.12%, respectively.

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.